152 lines
No EOL
22 KiB
XML
152 lines
No EOL
22 KiB
XML
<?xml version="1.0" encoding="utf-8"?>
|
||
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
|
||
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
|
||
|
||
<head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
|
||
<!-- AppResources meta begin -->
|
||
<meta name="paf-app-resources" content="" />
|
||
<script type="text/javascript">var ncbi_startTime = new Date();</script>
|
||
|
||
<!-- AppResources meta end -->
|
||
|
||
<!-- TemplateResources meta begin -->
|
||
<meta name="paf_template" content="" />
|
||
|
||
<!-- TemplateResources meta end -->
|
||
|
||
<!-- Logger begin -->
|
||
<meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK501569" /><meta name="ncbi_domain" content="lactmed" /><meta name="ncbi_report" content="printable" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK501569/?report=printable" /><meta name="ncbi_app" content="bookshelf" />
|
||
<!-- Logger end -->
|
||
|
||
<title>Technetium Tc 99m Pentetate - Drugs and Lactation Database (LactMed®) - NCBI Bookshelf</title>
|
||
|
||
<!-- AppResources external_resources begin -->
|
||
<link rel="stylesheet" href="/core/jig/1.15.2/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.15.2/js/jig.min.js"></script>
|
||
|
||
<!-- AppResources external_resources end -->
|
||
|
||
<!-- Page meta begin -->
|
||
<meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="Drugs and Lactation Database (LactMed®) [Internet]" /><meta name="citation_title" content="Technetium Tc 99m Pentetate" /><meta name="citation_publisher" content="National Institute of Child Health and Human Development" /><meta name="citation_date" content="2024/11/15" /><meta name="citation_pmid" content="30000629" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK501569/" /><meta name="citation_keywords" content="Technetium Tc 99m pentetate" /><meta name="citation_keywords" content="Techneplex" /><meta name="citation_keywords" content="AN-DTPA" /><meta name="citation_keywords" content="Tc 99m DTPA kit" /><meta name="citation_keywords" content="UNII-VW78417PU1" /><meta name="citation_keywords" content="VW78417PU1" /><meta name="citation_keywords" content="sodium" /><meta name="citation_keywords" content="2-[bis[2-[bis(carboxylatomethyl)amino]ethyl]amino]acetate" /><meta name="citation_keywords" content="technetium-99(4+)" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Technetium Tc 99m Pentetate" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="National Institute of Child Health and Human Development" /><meta name="DC.Date" content="2024/11/15" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK501569/" /><meta name="description" content="Information in this record refers to the use of technetium Tc 99m pentetate (Tc 99m-diethylenetriaminepentaacetic acid; Tc 99m DTPA) as a diagnostic agent. A US Nuclear Regulatory Commission subcommittee has recommended that nursing be discontinued for 24 hours after administration of all technetium Tc 99m diagnostic products to simplify guidance recommendations, although this time interval may be longer than necessary.[1] Several international agencies and organizations state that breastfeeding need not be interrupted after administration of Tc 99m DTPA in doses up to 1000 MBq (27 mCi) intravenously or by inhalation to a nursing mother.[2-5] However, to follow the principle of keeping exposure "as low as reasonably achievable", some experts recommend nursing the infant just before administration of the radiopharmaceutical and interrupting breastfeeding for 3 to 6 hours after the dose, then expressing the milk completely once and discarding it. If the mother has expressed and saved milk prior to the examination, she can feed it to the infant during the period of nursing interruption.[4,6,7] Mothers need not refrain from close contact with their infants after usual clinical doses.[8]" /><meta name="og:title" content="Technetium Tc 99m Pentetate" /><meta name="og:type" content="book" /><meta name="og:description" content="Information in this record refers to the use of technetium Tc 99m pentetate (Tc 99m-diethylenetriaminepentaacetic acid; Tc 99m DTPA) as a diagnostic agent. A US Nuclear Regulatory Commission subcommittee has recommended that nursing be discontinued for 24 hours after administration of all technetium Tc 99m diagnostic products to simplify guidance recommendations, although this time interval may be longer than necessary.[1] Several international agencies and organizations state that breastfeeding need not be interrupted after administration of Tc 99m DTPA in doses up to 1000 MBq (27 mCi) intravenously or by inhalation to a nursing mother.[2-5] However, to follow the principle of keeping exposure "as low as reasonably achievable", some experts recommend nursing the infant just before administration of the radiopharmaceutical and interrupting breastfeeding for 3 to 6 hours after the dose, then expressing the milk completely once and discarding it. If the mother has expressed and saved milk prior to the examination, she can feed it to the infant during the period of nursing interruption.[4,6,7] Mothers need not refrain from close contact with their infants after usual clinical doses.[8]" /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK501569/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-lactmed-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/lactmed/LM677/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK501569/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books_print.min.css" type="text/css" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace} .first-line-outdent .bk_ref {display: inline} </style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.26/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.26/books.min.js"> </script>
|
||
|
||
<!-- Page meta end -->
|
||
<link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8D442C7D83A5E100000000007D0074.m_5" />
|
||
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4216701/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3984801/12930/3964959.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/css/3411343/3882866.css" media="print" /></head>
|
||
<body class="book-part">
|
||
<div class="grid no_max_width">
|
||
<div class="col twelve_col nomargin shadow">
|
||
<!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
|
||
<div class="sysmessages">
|
||
<noscript>
|
||
<p class="nojs">
|
||
<strong>Warning:</strong>
|
||
The NCBI web site requires JavaScript to function.
|
||
<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
|
||
</p>
|
||
</noscript>
|
||
</div>
|
||
<!--/.sysmessage-->
|
||
<div class="wrap">
|
||
<div class="page">
|
||
<div class="top">
|
||
|
||
<div class="header">
|
||
|
||
|
||
</div>
|
||
|
||
|
||
|
||
<!--<component id="Page" label="headcontent"/>-->
|
||
|
||
</div>
|
||
<div class="content">
|
||
<!-- site messages -->
|
||
<div class="container content">
|
||
<div class="document">
|
||
<div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-. </p></div></div></div>
|
||
<div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK501569_"><span class="title" itemprop="name">Technetium Tc 99m Pentetate</span></h1><p class="small">Last Revision: <span itemprop="dateModified">November 15, 2024</span>.</p><p><em>Estimated reading time: 2 minutes</em></p></div><div class="body-content whole_rhythm" itemprop="text"><p>CASRN: 65454-61-7</p><a href="https://pubchem.ncbi.nlm.nih.gov/substance/135007795" title="View this structure in PubChem" class="img_link" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem"><img src="https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?t=l&sid=135007795" alt="image 135007795 in the ncbi pubchem database" /></a><div id="LM677.Drug_Levels_and_Effects"><h2 id="_LM677_Drug_Levels_and_Effects_">Drug Levels and Effects</h2><div id="LM677.Summary_of_Use_during_Lactation"><h3>Summary of Use during Lactation</h3><p>Information in this record refers to the use of technetium Tc 99m pentetate (Tc 99m-diethylenetriaminepentaacetic acid; Tc 99m DTPA) as a diagnostic agent. A US Nuclear Regulatory Commission subcommittee has recommended that nursing be discontinued for 24 hours after administration of all technetium Tc 99m diagnostic products to simplify guidance recommendations, although this time interval may be longer than necessary.[<a class="bk_pop" href="#LM677.REF.1">1</a>] Several international agencies and organizations state that breastfeeding need not be interrupted after administration of Tc 99m DTPA in doses up to 1000 MBq (27 mCi) intravenously or by inhalation to a nursing mother.[<a class="bk_pop" href="#LM677.REF.2">2</a>-<a class="bk_pop" href="#LM677.REF.5">5</a>] However, to follow the principle of keeping exposure "as low as reasonably achievable", some experts recommend nursing the infant just before administration of the radiopharmaceutical and interrupting breastfeeding for 3 to 6 hours after the dose, then expressing the milk completely once and discarding it. If the mother has expressed and saved milk prior to the examination, she can feed it to the infant during the period of nursing interruption.[<a class="bk_pop" href="#LM677.REF.4">4</a>,<a class="bk_pop" href="#LM677.REF.6">6</a>,<a class="bk_pop" href="#LM677.REF.7">7</a>] Mothers need not refrain from close contact with their infants after usual clinical doses.[<a class="bk_pop" href="#LM677.REF.8">8</a>]</p><p>Mothers concerned about the level of radioactivity in their milk could ask to have it tested at a nuclear medicine facility at their hospital. When the radioactivity is at a safe level, she may resume breastfeeding. A method for measuring milk radioactivity and determining the time when a mother can safely resume breastfeeding has been published.[<a class="bk_pop" href="#LM677.REF.9">9</a>]</p><p>For nursing mothers who work with Tc 99m substances in their workplace, there is no need to take any precautions other than those appropriate for general radiation protection.[<a class="bk_pop" href="#LM677.REF.10">10</a>]</p></div><div id="LM677.Drug_Levels"><h3>Drug Levels</h3><p>Tc 99m is a gamma emitter with a principal photon energy of 140 keV and a physical half-life of 6.04 hours.[<a class="bk_pop" href="#LM677.REF.1">1</a>] The effective half-life of Tc 99m DTPA ranges from 3.1 to 5 hours).[<a class="bk_pop" href="#LM677.REF.6">6</a>,<a class="bk_pop" href="#LM677.REF.9">9</a>,<a class="bk_pop" href="#LM677.REF.11">11</a>] About 41% is assumed to reach the bloodstream after aerosol inhalation and about 0.012% of a dose reaches breastmilk.[<a class="bk_pop" href="#LM677.REF.9">9</a>,<a class="bk_pop" href="#LM677.REF.11">11</a>]</p></div><div id="LM677.Effects_in_Breastfed_Infants"><h3>Effects in Breastfed Infants</h3><p>Relevant published information was not found as of the revision date.</p></div><div id="LM677.Effects_on_Lactation_and_Breastmil"><h3>Effects on Lactation and Breastmilk</h3><p>Relevant published information was not found as of the revision date.</p></div><div id="LM677.Alternate_Drugs_to_Consider"><h3>Alternate Drugs to Consider</h3><p>
|
||
<a href="/books/n/lactmed/LM678/">Technetium Tc 99m Ethylenedicysteine</a>
|
||
</p></div><div id="LM677.References"><h3>References</h3><dl class="temp-labeled-list"><dt>1.</dt><dd><div class="bk_ref" id="LM677.REF.1">Dilsizian V, Metter D, Palestro C, et al. Advisory Committee on Medical Uses of Isotopes (ACMUI) Sub-Committee on Nursing Mother Guidelines for the Medical Administration of Radioactive Material. Final report submitted: January 31, 2019. 2019. <a href="https://www.nrc.gov/docs/ML1903/ML19038A498.pdf" ref="pagearea=cite-ref&targetsite=external&targetcat=link&targettype=uri">https://www<wbr style="display:inline-block"></wbr>.nrc.gov/docs<wbr style="display:inline-block"></wbr>/ML1903/ML19038A498.pdf</a></div></dd><dt>2.</dt><dd><div class="bk_ref" id="LM677.REF.2">Mattsson
|
||
S, Johansson
|
||
L, Leide Svegborn
|
||
S, et al.
|
||
Radiation dose to patients from radiopharmaceuticals: A compendium of current information related to frequently used substances. ICRP Publication 128. Annex D. Recommendations on breast-feeding interruptions.
|
||
Ann ICRP
|
||
2015;44:7-321. doi:10.1177/0146645314558019
|
||
[<a href="https://pubmed.ncbi.nlm.nih.gov/26069086" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 26069086</span></a>] [<a href="http://dx.crossref.org/10.1177/0146645314558019" ref="pagearea=cite-ref&targetsite=external&targetcat=link&targettype=uri">CrossRef</a>]</div></dd><dt>3.</dt><dd><div class="bk_ref" id="LM677.REF.3">ARSAC notes for guidance: Good clinical practice in nuclear medicine. Notes for guidance on the clinical administration of radiopharmaceuticals and use of sealed radioactive sources. 2020. <a href="https://www.gov.uk/government/publications/arsac-notes-for-guidance" ref="pagearea=cite-ref&targetsite=external&targetcat=link&targettype=uri">https://www<wbr style="display:inline-block"></wbr>.gov.uk/government<wbr style="display:inline-block"></wbr>/publications<wbr style="display:inline-block"></wbr>/arsac-notes-for-guidance</a> [<a href="https://pubmed.ncbi.nlm.nih.gov/10732169" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10732169</span></a>]</div></dd><dt>4.</dt><dd><div class="bk_ref" id="LM677.REF.4">Stabin M. Doses from medical radiation sources. <a href="https://hps.org/hpspublications/articles/dosesfrommedicalradiation.html" ref="pagearea=cite-ref&targetsite=external&targetcat=link&targettype=uri">https://hps<wbr style="display:inline-block"></wbr>.org/hpspublications<wbr style="display:inline-block"></wbr>/articles<wbr style="display:inline-block"></wbr>/dosesfrommedicalradiation.html</a>. Accessed Nov 6, 2024.</div></dd><dt>5.</dt><dd><div class="bk_ref" id="LM677.REF.5">Mitchell
|
||
K, Fleming
|
||
M, Anderson
|
||
P, et al.
|
||
ABM Clinical Protocol #30: Radiology and nuclear medicine studies in lactating women.
|
||
Breastfeed Med
|
||
2019;14:290-4.
|
||
[<a href="https://pubmed.ncbi.nlm.nih.gov/31107104" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 31107104</span></a>]</div></dd><dt>6.</dt><dd><div class="bk_ref" id="LM677.REF.6">Mountford
|
||
P, Coakley
|
||
A.
|
||
A review of the secretion of radioactivity in human breast milk: Data, quantitative analysis and recommendations.
|
||
Nucl Med Commun
|
||
1989;10:15-27.
|
||
[<a href="https://pubmed.ncbi.nlm.nih.gov/2645546" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 2645546</span></a>]</div></dd><dt>7.</dt><dd><div class="bk_ref" id="LM677.REF.7">International Atomic Energy Agency. Radiation Protection and Safety in Medical Uses of Ionizing Radiation, IAEA Safety Standards Series No. SSG-46, IAEA, Vienna. 2018. <a href="https://www.iaea.org/publications/11102/radiation-protection-and-safety-in-medical-uses-of-ionizing-radiation" ref="pagearea=cite-ref&targetsite=external&targetcat=link&targettype=uri">https://www<wbr style="display:inline-block"></wbr>.iaea.org<wbr style="display:inline-block"></wbr>/publications/11102/radiation-protection-and-safety-in-medical-uses-of-ionizing-radiation</a></div></dd><dt>8.</dt><dd><div class="bk_ref" id="LM677.REF.8">Mountford
|
||
P, O'Doherty
|
||
M. Exposure of critical groups to nuclear medicine patients.
|
||
Appl Radiat Isot
|
||
1999;50:89-111.
|
||
[<a href="https://pubmed.ncbi.nlm.nih.gov/10028630" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10028630</span></a>]</div></dd><dt>9.</dt><dd><div class="bk_ref" id="LM677.REF.9">Stabin
|
||
M, Breitz
|
||
H. Breast milk excretion of radiopharmaceuticals: Mechanisms, findings, and radiation dosimetry.
|
||
J Nucl Med
|
||
2000;41:863-73.
|
||
[<a href="https://pubmed.ncbi.nlm.nih.gov/10809203" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10809203</span></a>]</div></dd><dt>10.</dt><dd><div class="bk_ref" id="LM677.REF.10">Almén
|
||
A, Mattsson
|
||
S. Radiological protection of foetuses and breast-fed children of occupationally exposed women in nuclear medicine - Challenges for hospitals.
|
||
Phys Med
|
||
2017;43:172-7.
|
||
[<a href="https://pubmed.ncbi.nlm.nih.gov/28882410" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 28882410</span></a>]</div></dd><dt>11.</dt><dd><div class="bk_ref" id="LM677.REF.11">Leide-Svegborn
|
||
S, Ahlgren
|
||
L, Johansson
|
||
L, et al.
|
||
Excretion of radionuclides in human breast milk after nuclear medicine examinations. Biokinetic and dosimetric data and recommendations on breastfeeding interruption.
|
||
Eur J Nucl Med Mol Imaging
|
||
2016;43:808-21.
|
||
[<a href="https://pubmed.ncbi.nlm.nih.gov/26732471" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 26732471</span></a>]</div></dd></dl></div></div><div id="LM677.Substance_Identification"><h2 id="_LM677_Substance_Identification_">Substance Identification</h2><div id="LM677.Substance_Name"><h3>Substance Name</h3><p>Technetium Tc 99m Pentetate</p></div><div id="LM677.CAS_Registry_Number"><h3>CAS Registry Number</h3><p>65454-61-7</p></div><div id="LM677.Drug_Class"><h3>Drug Class</h3><p>Breast Feeding</p><p>Lactation</p><p>Milk, Human</p><p>Radiopharmaceuticals</p><p>Technetium Compounds</p><p>Diagnostic Agents</p></div></div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_top_margin"><p><b>Disclaimer: </b>Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.</p></p></div></dd></dl></div><div id="bk_toc_contnr"></div></div></div>
|
||
<div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright Notice</a><p class="small"><b>Attribution Statement:</b> LactMed is a registered trademark of the U.S. Department of Health and Human Services.</p></div><div class="small"><span class="label">Bookshelf ID: NBK501569</span><span class="label">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/30000629" title="PubMed record of this page" ref="pagearea=meta&targetsite=entrez&targetcat=link&targettype=pubmed">30000629</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/lactmed/">Contents</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/lactmed/LM683/" title="Previous page in this title">< Prev</a><a class="active page_link next" href="/books/n/lactmed/LM686/" title="Next page in this title">Next ></a></div></div></div></div>
|
||
|
||
</div>
|
||
</div>
|
||
</div>
|
||
<div class="bottom">
|
||
|
||
<div id="NCBIFooter_dynamic">
|
||
<!--<component id="Breadcrumbs" label="breadcrumbs"/>
|
||
<component id="Breadcrumbs" label="helpdesk"/>-->
|
||
|
||
</div>
|
||
|
||
<script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js"> </script>
|
||
</div>
|
||
</div>
|
||
<!--/.page-->
|
||
</div>
|
||
<!--/.wrap-->
|
||
</div><!-- /.twelve_col -->
|
||
</div>
|
||
<!-- /.grid -->
|
||
|
||
<span class="PAFAppResources"></span>
|
||
|
||
<!-- BESelector tab -->
|
||
|
||
|
||
|
||
<noscript><img alt="statistics" src="/stat?jsdisabled=true&ncbi_db=books&ncbi_pdid=book-part&ncbi_acc=NBK501569&ncbi_domain=lactmed&ncbi_report=printable&ncbi_type=fulltext&ncbi_objectid=&ncbi_pcid=/NBK501569/?report=printable&ncbi_app=bookshelf" /></noscript>
|
||
|
||
|
||
<!-- usually for JS scripts at page bottom -->
|
||
<!--<component id="PageFixtures" label="styles"></component>-->
|
||
|
||
|
||
<!-- CE8B5AF87C7FFCB1_0191SID /projects/books/PBooks@9.11 portal106 v4.1.r689238 Tue, Oct 22 2024 16:10:51 -->
|
||
<span id="portal-csrf-token" style="display:none" data-token="CE8B5AF87C7FFCB1_0191SID"></span>
|
||
|
||
<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/js/3879255/4121861/3501987/4008961/3893018/3821238/3400083/3426610.js" snapshot="books"></script></body>
|
||
</html> |